Abstract Objective To investigate the protective effect of succinic acid (SA) on the cerebellar Purkinje cells (PCs) of neonatal rats with convulsion. Methods A total of 120 healthy neonatal Sprague-Dawley rats aged 7 days were randomly divided into a neonatal period group and a developmental period group. Each of the two groups were further divided into 6 sub-groups: normal control, convulsion model, low-dose phenobarbital (PB) (30 mg/ kg), high-dose PB (120 mg/kg), low-dose SA (30 mg/kg), and high-dose SA (120 mg/kg). Intraperitoneal injection of pentylenetetrazole was performed to establish the convulsion model. The normal control group was treated with normal saline instead. The rats in the neonatal group were sacrificed at 30 minutes after the injection of PB, SA, or normal saline, and the cerebellum was obtained. Those in the developmental group were sacrificed 30 days after the injection of PB, SA, or normal saline, and the cerebellum was obtained. Whole cell patch clamp technique was used to record the action potential (AP) of PCs in the cerebellar slices of neonatal rats; the parallel fibers (PF) were stimulated at a low frequency to induce excitatory postsynaptic current (EPSC). The effect of SA on long-term depression (LTD) of PCs was observed. Results Compared with the normal control groups, the neonatal and developmental rats with convulsion had a significantly higher AP frequency of PCs (PPPPPPPPConclusions The high excitability of PCs and the abnormal PF-PC synaptic plasticity caused by convulsion in neonatal rats may last to the developmental period, which can be aggravated by PB, while SA can reduce the excitability of PCs in neonatal rats with convulsion and repair the short-and long-term abnormalities of LTD of PCs caused by convulsion.
ZHANG Jing,CHEN Jing,TAN Xiao-Li et al. Protective effect of succinic acid on cerebellar Purkinje cells of neonatal rats with convulsion[J]. CJCP, 2016, 18(1): 85-93.
ZHANG Jing,CHEN Jing,TAN Xiao-Li et al. Protective effect of succinic acid on cerebellar Purkinje cells of neonatal rats with convulsion[J]. CJCP, 2016, 18(1): 85-93.
Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures[J]. Semin Fetal Neonatal Med, 2013, 18(4): 185-191.
[2]
Castelhano AS, Cassane Gdos S, Scorza FA, et al. Altered anxiety-related and abnormal social behaviors in rats exposed to early life seizures[J]. Front Behav Neurosci, 2013, 7: 36.
[3]
Sayin U, Hutchinson E, Meyerand ME, et al. Age-dependent long-term structural and functional effects of early-life seizures: evidence for a hippocampal critical period influencing plasticity in adulthood[J]. Neuroscience, 2015, 288: 120-134.
[4]
Glass HC. Neonatal seizures: advances in mechanisms and management[J]. Clin Perinatol, 2014, 41(1): 177-190.
[5]
Cornejo BJ, Mesches MH, Coultrap S, et al. A single episode of neonatal seizures permanently alters glutamatergic synapses[J]. Ann Neurol, 2007, 61(5): 411-426.
[6]
Forcelli PA, Janssen MJ, Vicini S, et al. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development[J]. Ann Neurol, 2012, 72(3): 363-372.
[7]
Gutherz SB, Kulick CV, Soper C, et al. Brief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats[J]. Epilepsy Behav, 2014, 37: 265-269.
[8]
Bhardwaj SK, Forcelli PA, Palchik G, et al. Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat[J]. Neuropharmacology, 2012, 62(7): 2337-2345.
Yue W, Liu YX, Zang DL, et al. Inhibitory effects of succinic acid on chemical kindling and amygdala electrical kindling in rats[J]. Acta Pharmacol Sin, 2002, 23(9): 847-850.
Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations[J]. Epilepsy Res, 1988, 2(3): 145-181.
[14]
Craig CR, Colasanti BK. A study of pentylenetetrazol kindling in rats and mice[J]. Pharmacol Biochem Behav, 1988, 31(4): 867-870.
[15]
Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure[J]. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281-294.
[16]
Kikuchi K, Hamano S, Oritsu T, et al. Effectiveness and safety of non-intravenous high-dose phenobarbital therapy for intractable epilepsy during childhood[J]. Brain Dev, 2011, 33(5): 379-383.
Schulz DW, Macdonald RL. Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: correlation with anticonvulsant and anesthetic actions[J]. Brain Res, 1981, 209(1): 177-188.
[20]
Ben-Ari Y. The GABA excitatory/inhibitory developmental sequence: a personal journey[J]. Neuroscience, 2014, 279: 187-219.
Kohda K, Kakegawa W, Yuzaki M. Unlocking the secrets of the δ2 glutamate receptor: a gatekeeper for synaptic plasticity in the cerebellum[J]. Commun Integr Biol, 2013, 6(6): e26466.
Ito M, Yamaguchi K, Nagao S, et al. Long-term depression as a model of cerebellar plasticity[J]. Prog Brain Res, 2014, 210: 1-30.
[26]
D'Angelo E. The organization of plasticity in the cerebellar cortex: from synapses to control[J]. Prog Brain Res, 2014, 210: 31-58.
[27]
Chen J, Cai F, Cao J, et al. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain[J]. J Neurosci Res, 2009, 87(13): 2898-2907.
[28]
Verrotti A, Scaparrotta A, Cofini M, et al. Developmental neurotoxicity and anticonvulsant drugs: a possible link[J]. Reprod Toxicol, 2014, 48: 72-80.
